Lymphoblastic Lymphoma

Birgit Burkhardt, Birte Wistinghausen

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Lymphoblastic lymphoma (LBL) is the second most common type of non-Hodgkin lymphoma (NHL) in childhood and adolescence accounting for 25-35% of all cases. The majority, 70-80%, is of T-lymphoblastic origin, and 20-25% arise from B-lymphoblasts. With intensification of therapy in the last decades, the event-free and overall survivals for pediatric LBL patients are now exceeding 80%, but the burden of therapy causes considerable morbidity and late sequela. In addition, the prognosis of relapsed patients remains poor (Schmidt and Burkhardt. Pediatr Hematol Oncol. 30:484-508, 2013). This chapter will focus on the pathogenesis and biology of LBL, recent advances in the therapy of LBL, and ongoing and future efforts in optimizing therapy and developing novel targeted treatment approaches.

Original languageEnglish
Title of host publicationNon-Hodgkin’s Lymphoma in Childhood and Adolescence
PublisherSpringer International Publishing
Number of pages12
ISBN (Electronic)9783030117696
ISBN (Print)9783030117689
StatePublished - 1 Jan 2019
Externally publishedYes


  • Adolescents
  • Children
  • Lymphoblastic lymphoma
  • Precursor b cell
  • Precursor t cell


Dive into the research topics of 'Lymphoblastic Lymphoma'. Together they form a unique fingerprint.

Cite this